Episode 025: Lung Cancer Series, Pt. 3: Specialized diagnostic workup in NSCLC episode artwork

EPISODE · Aug 17, 2022

Episode 025: Lung Cancer Series, Pt. 3: Specialized diagnostic workup in NSCLC

from The Fellow on Call: The Heme/Onc Podcast · host TheFellowOnCall HemeOncPodcast

Lung cancer specialized testing in NSCLC: What do we do if we biopsy a suspected metastatic lesion?* Immunohistochemistry (IHC): **Confirm if it is metastatic NSCLC **Confirms the histology of the NSCLC (such as adenocarcinoma vs. squamous cell)**Used to determine the type of chemotherapy that can be administered for treatment *PDL1 testing: **PDL1 is a protein expressed by certain cancer cells allowing them to evade the immune system (“fake mustache analogy”).**Also confirmed by IHC**This protein is targetable!**Often measured as:***Total protein expression (TPS): The number of positive tumor cells divided by the total number of viable tumor cells multiplied by 100%***Composite protein expression (CPS): The number of positive tumor cells, lymphocytes and macrophages, divided by the total number of viable tumor cells multiplied by 100%*Molecular testing: **We discuss this in detail in Episode 005**Genetic information from the tissue sample**Always better to get sample from soft tissue than from bone**Why is this important?***To be able to identify “driver mutations”****What is it? Important mutations that may be “driving” oncogenesis****Many of these have drugs that directly target these mutationsPrognostic vs. predictive biomarkers:*Prognostic biomarkers: Mutations or changes that give information about the cancer’s overall outcome regardless of therapy*Predictive biomarkers: Mutations that provide information about how a cancer may respond to a particular drug Cell-free DNA (AKA “liquid biopsy”):*Special tests that can detect microscopic amounts of cancer cell DNA within the patient’s blood which may also be used to find prognostic/predictive biomarkers*Ongoing studies to see if this can be used to find relapse of diseasePlease visit our website (TheFellowOnCall.com) for more information Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Lung cancer specialized testing in NSCLC: What do we do if we biopsy a suspected metastatic lesion? * Immunohistochemistry (IHC): **Confirm if it is metastatic NSCLC **Confirms the histology of the NSCLC (such as adenocarcinoma vs. squamous cell) **Used to determine the type of chemotherapy that can be administered for treatment *PDL1 testing: **PDL1 is a protein expressed by certain cancer cells allowing them to evade the immune system (“fake mustache analogy”). **Also confirmed by IHC **This protein is targetable! **Often measured as: ***Total protein expression (TPS): The number of positive tumor cells divided by the total number of viable tumor cells multiplied by 100% ***Composite protein expression (CPS): The number of positive tumor cells, lymphocytes and macrophages, divided by the total number of viable tumor cells multiplied by 100% *Molecular testing: **We discuss this in detail in Episode 005 **Genetic information from the tissue sample **Always better to get sample from soft tissue than from bone **Why is this important? ***To be able to identify “driver mutations” ****What is it? Important mutations that may be “driving” oncogenesis ****Many of these have drugs that directly target these mutations Prognostic vs. predictive biomarkers: *Prognostic biomarkers: Mutations or changes that give information about the cancer’s overall outcome regardless of therapy *Predictive biomarkers: Mutations that provide information about how a cancer may respond to a particular drug Cell-free DNA (AKA “liquid biopsy”): *Special tests that can detect microscopic amounts of cancer cell DNA within the patient’s blood which may also be used to find prognostic/predictive biomarkers *Ongoing studies to see if this can be used to find relapse of disease Please visit our website (TheFellowOnCall.com) for more information Twitter: @TheFellowOnCall Instagram: @TheFellowOnCall Listen in on: Apple Podcast, Spotify, and Google Podcast

NOW PLAYING

Episode 025: Lung Cancer Series, Pt. 3: Specialized diagnostic workup in NSCLC

0:00 0:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Fellow on Call: The Heme/Onc Podcast?

Episode duration information is not available.

When was this The Fellow on Call: The Heme/Onc Podcast episode published?

This episode was published on August 17, 2022.

What is this episode about?

Lung cancer specialized testing in NSCLC: What do we do if we biopsy a suspected metastatic lesion?* Immunohistochemistry (IHC): **Confirm if it is metastatic NSCLC **Confirms the histology of the NSCLC (such as adenocarcinoma vs. squamous...

Can I download this The Fellow on Call: The Heme/Onc Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!